Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2024
  • December
  • Page 7
electrocore-to-buy-neurometrix-and-its-quell-fibromyalgia-wearable-stimulator
Posted inMedical Technology

ElectroCore to buy NeuroMetrix and its Quell fibromyalgia wearable stimulator

December 19, 2024
Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and…
Read More
uncovering-craniopharyngioma’s-growth-mechanism-may-identify-new-therapy
Posted inGenetics

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy

December 19, 2024
Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…
Read More
former-seagen-ceo’s-biotech-raises-$140m-series-a-to-ready-pd1/vegfr2-antibody-for-clinic
Posted inBiotechnology

Former Seagen CEO’s biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic

December 19, 2024
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in…
Read More
fda-elevates-boston-scientific-cryoablation-correction-effort-following-four-deaths
Posted inMedical Technology

FDA elevates Boston Scientific cryoablation correction effort following four deaths

December 19, 2024
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation.…
Read More
bms-pays-leqembi-originator-$100m-for-next-gen-preclinical-alzheimer’s-prospects
Posted inBiotechnology

BMS pays Leqembi originator $100M for next-gen preclinical Alzheimer’s prospects

December 19, 2024
Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million…
Read More
roche-reports-failure-of-prothena-partnered-parkinson’s-prospect-in-phase-2b-but-highlights-positives
Posted inBiotechnology

Roche reports failure of Prothena-partnered Parkinson’s prospect in phase 2b but highlights positives

December 19, 2024
Back-to-back clinical failures have dealt further blows to efforts to treat Parkinson’s disease by targeting alpha-synuclein. Days after UCB reported the…
Read More
astellas-pays-sangamo-$20m-upfront-to-improve-neurological-gene-therapy-capabilities
Posted inBiotechnology

Astellas pays Sangamo $20M upfront to improve neurological gene therapy capabilities

December 19, 2024
Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 million upfront to help bypass…
Read More
akamis-bio-raises-$60-million-for-cancer-gene-therapy,-signs-licensing-deal-with-xuanzhu-biopharma
Posted inGenetics

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

December 19, 2024
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…
Read More
mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More

Posts pagination

Previous page 1 … 5 6 7 8 9 … 14 Next page

Privacy Policy    Terms

Scroll to Top